ANDROGRAPHOLIDE DERIVATIVES FOR USE IN THE TREATMENT OF COVID-19 DISEASE AND PULMONARY FIBROSIS ASSOCIATED WITH COVID-19

Patent number:

No items found.

Disclosed are andrographolide derivatives for use as an antiviral agent in the treatment of COVID-19 disease or pulmonary fibrosis associated with COVID-19.

Countries:

Spain

Regions:

Valencian Community

Navarre

Centers:

CSIC, UNIVERSITAT DE VALENCIA, FUNDACION PARA LA INVESTIG MEDICA APLICADA, UNIVERSIDAD PUBLICA DE NAVARRA, UNIVERSITAT POLITECNICA DE VALENCIA, FUNDACION PARA LA INVESTIGACION MEDICA APLICADA, UNIVERSIDAD DE NAVARRA

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 3 – experimental proof of concept

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

Comments

Other related patents

Health

Use of TRF1 inhibitors for the treatment or prevention of brain cancer

Countries

Spain

Food & Agro

Health

VOLATILE ORGANIC COMPOUND CHAMBER (VOC CHAMBER) FOR THE PERFORMANCE OF MICROBIOLOGICAL VOLATILE INTERACTION ASSAYS

Countries

Spain

Health

COMPOSITION COMPRISING VANCOMYCIN AND ORLISTAT

Countries

Belgium

Get back to patents directory